BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Merck
Express Scripts
Citi
Daiichi Sankyo
Harvard Business School
Medtronic
McKesson
Boehringer Ingelheim
Fuji

Generated: January 22, 2018

DrugPatentWatch Database Preview

METHYLTESTOSTERONE Drug Profile

« Back to Dashboard

When do Methyltestosterone patents expire, and what generic alternatives are available?

Methyltestosterone is a drug marketed by Heather, Impax Labs Inc, Impax Labs, Lilly, Purepac Pharm, Pvt Form, Tablicaps, Usl Pharma, Inwood Labs, Kv Pharm, Lannett, Parke Davis, Watson Labs, and West Ward. and is included in twenty-seven NDAs.

The generic ingredient in METHYLTESTOSTERONE is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
Drug patent expirations by year for METHYLTESTOSTERONE
Pharmacology for METHYLTESTOSTERONE
Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for METHYLTESTOSTERONE

US Patents and Regulatory Information for METHYLTESTOSTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West Ward METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 084331-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tablicaps METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 085270-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West Ward METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 084642-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 080933-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Heather METHYLTESTOSTERONE methyltestosterone CAPSULE;ORAL 084967-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 087092-001 Nov 5, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pvt Form METHYLTESTOSTERONE methyltestosterone TABLET;ORAL 080214-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm METHYLTESTOSTERONE methyltestosterone TABLET;BUCCAL, SUBLINGUAL 080475-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly METHYLTESTOSTERONE methyltestosterone TABLET;BUCCAL, SUBLINGUAL 080256-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma METHYLTESTOSTERONE methyltestosterone TABLET;BUCCAL, SUBLINGUAL 080271-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Moodys
Teva
Chinese Patent Office
Cipla
Julphar
AstraZeneca
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot